Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats

Journal of Veterinary Internal Medicine

Volumn 22, Issue 2, 2008, Pages 330-334

  Levy, Julie K ^a   Crawford, P C ^a   Kusuhara, H ^b   Motokawa, K ^b   Gemma, T ^b   Watanabe, R ^b   Arai, S ^b   Bienzle, D ^c   Hohdatsu, T ^d  

^a University of Florida College of Veterinary Medicine   (United States)

^b KITASATO INSTITUTE   (Japan)

^c UNIVERSITY OF GUELPH   (Canada)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

Diagnosis; ELISA; Serology; Viral culture

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; DISCRIMINANT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FELINE IMMUNODEFICIENCY VIRUS; GERMFREE ANIMAL; IMMUNOLOGY; ISOLATION AND PURIFICATION; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CATS; DISCRIMINANT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNODEFICIENCY VIRUS, FELINE; SENSITIVITY AND SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL VACCINES;

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS;

EID: 42449108251     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0078.x     Document Type: Article

References (18)

1. Levy JK, Scott HM, Lachtara JL, Crawford PC. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J Am Vet Med Assoc 2006;228:371-376.
2. Huang C, Conlee D, Loop J, et al. Efficacy and safety of a feline immunodeficiency virus vaccine. Anim Health Res Rev 2004;5:295-300.
3. Kusuhara H, Hohdatsu T, Seta T, et al. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats. Vet Microbiol 2007;120:217-225.
4. Levy JK, Crawford PC, Slater MR. Effect of vaccination against feline immunodeficiency virus on results of serological testing in cats. J Am Vet Med Assoc 2004;225:1558-1561.
5. Andersen PR, Tyrrell P. Feline immunodeficiency virus diagnosis after vaccination. Anim Health Res Rev 2004;5:327-330.
6. Richards JR. Feline immunodeficiency virus vaccine: Implications for diagnostic testing and disease management. Biologicals 2005;33:215-217.
7. Crawford PC, Levy JK. New challenges for the diagnosis of feline immunodeficiency virus infection. Vet Clin North Am Small Anim Pract 2007;37:335-350.
8. Crawford PC, Slater MR, Levy JK. Accuracy of polymerase chain reaction for diagnosis of FIV infection. J Am Vet Med Assoc 2005;226:1503-1507.
9. Zislin A. Feline immunodeficiency virus vaccine: A rational paradigm for clinical decision-making. Biologicals 2005;33: 219-220.
10. MacDonald K, Levy JK, Tucker SJ, Crawford PC. Effects of passive transfer of immunity on results of diagnostic tests for antibodies against feline immunodeficiency virus in kittens born to vaccinated queens. J Am Vet Med Assoc 2004;225:1554-1557.
11. Levy JK, Richards J, Edwards D, et al. Feline retrovirus testing and management. Comp Continuing Ed Practicing Veterinarian 2001;23:652-657, 692.
12. Willett BJ, McMonagle EL, Logan N, et al. Vaccine protection against feline immunodeficiency virus: Setting the challenge. Aust Vet J 2007;85:5-12.
13. Henderson LM. Overview of marker vaccine and differential diagnostic test technology. Biologicals 2005;33:203-209.
14. Bienzle D, Reggeti F, Wen X, et al. The variability of serological and molecular diagnosis of feline immunodeficiency virus infection. Can Vet J 2004;45:753-757.
15. Crawford PC, Papadi GP, Levy JK, et al. Tissue dynamics of CD8 lymphocytes that suppress virus replication in cats infected neonatally with feline immunodeficiency virus. J Infect Dis 2001;184:671-681.
16. Richards JR, Elston TH, Ford RB, et al. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report. J Am Vet Med Assoc 2006;229:1405-1441.
17. Kusuhara H, Hohdatsu T, Okumura M, et al. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats. Vet Microbiol 2005;108:155-165.
18. Enoe C, Georgiadis MP, Johnson WO. Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown. Prev Vet Med 2000;45: 61-81.